Showing results (121-130 of 157) with videos related to
Sort By:
Pageof 16
Human Immunology|June 29, 2004
HLA-A and -B allele expression and ability to develop anti-Gag cross-clade responses in subtype C HIV-1-infected EthiopiansGuido Ferrari, Jeffrey R Currier, Matthew E Harris, et al.AIDS Research and Human Retroviruses|October 17, 2001
Immunologic and virologic analyses of an acutely HIV type 1-infected patient with extremely rapid disease progressionJ F Demarest, N Jack, F R Cleghorn, et al.Cells|June 2, 2021
Physiological Fitness and the Pathophysiology of Chronic Lymphocytic Leukemia (CLL)Andrea Sitlinger, Michael A Deal, Erwin Garcia, et al.The Journal of Infectious Diseases|February 1, 1996
A dose-ranging study of a prototype synthetic HIV-1MN V3 branched peptide vaccine. The National Institute of Allergy and Infectious Diseases AIDS Vaccine Evaluation GroupG J Gorse, M C Keefer, R B Belshe, et al.Mucosal Immunology|January 10, 2013
HIV-1 gp41 envelope IgA is frequently elicited after transmission but has an initial short response half-lifeN L Yates, A R Stacey, T L Nolen, et al.Plos One|August 14, 2010
Immunization with cocktail of HIV-derived peptides in montanide ISA-51 is immunogenic, but causes sterile abscesses and unacceptable reactogenicityBarney S Graham, M Juliana McElrath, Michael C Keefer, et al.AIDS (London, England)|January 6, 1999
Induction of immune responses to HIV-1 by canarypox virus (ALVAC) HIV-1 and gp120 SF-2 recombinant vaccines in uninfected volunteers. NIAID AIDS Vaccine Evaluation GroupR B Belshe, G J Gorse, M J Mulligan, et al.Cytometry. Part a : the Journal of the International Society for Analytical Cytology|July 8, 2011
High-throughput quantitative analysis of HIV-1 and SIV-specific ADCC-mediating antibody responsesJustin Pollara, Lydia Hart, Faraha Brewer, et al.Scientific Reports|July 17, 2019
HLA class II-Restricted CD8+ T cells in HIV-1 Virus ControllersTinashe E Nyanhete, Alyse L Frisbee, Todd Bradley, et al.The Journal of Infectious Diseases|March 20, 2004
Comparison of systemic and mucosal delivery of 2 canarypox virus vaccines expressing either HIV-1 genes or the gene for rabies virus G proteinPeter F Wright, Jiri Mestecky, M Juliana McElrath, et al.Pageof 16